Evidence map›Paper›PMID 38774858›Full record

ArticleGalen medical journal2023

Emerging Biomarkers of Acute Myocardial Infarction, An Overview of the Newest MicroRNAs.

Venus Shahabi Raberi, Elnaz Javanshir, Mohsen Abbasnezhad, Sina Mashayekhi, Amirreza Abbasnezhad, Masumeh Ahmadzadeh, Akram Shariati

Abstract read
In one paragraph

Article in Galen medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Venus Shahabi RaberiSeyed-Al-Shohada Cardiology Hospital, Urmia University of Medical Sciences, Urmia, Iran.
Elnaz JavanshirCardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Mohsen AbbasnezhadCardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Sina MashayekhiCardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Amirreza AbbasnezhadFaculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Masumeh AhmadzadehCardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Akram ShariatiDepartment of Cardiology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Globally, acute myocardial infarction (AMI) is the leading cause of death. Early and precise diagnosis is essential for medical care to enhance prognoses and reduce mortality. The diagnosis of AMI relies primarily on conventional circulating biomarkers. However, these markers have many drawbacks. Non-coding RNAs (ncRNAs) form a significant fraction of the transcriptome and have been shown to be essential for many biological processes, including the pathogenesis of the disease. ncRNAs can be utilized as biomarkers due to their important role in the disease's development. The current manuscript describes recent progress on the role of ncRNAs as new AMI biomarkers.

Indexed as

BiomarkerLcnRNAMyocardial

Identifiers

PMID38774858
PMCPMC11108668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.